Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial. (nature.com)

Authors: Erameh C … Groger M Journal: Nature Medicine Published: 2026-05-15 DOI: https://doi.org/10.1038/s41591-026-04402-w